| Dr Thomas Shaw, PHARMD | |
|
13260 N 94th Dr Ste 102, Peoria, AZ 85381-4242 | |
| (623) 583-2045 | |
| (888) 605-4090 |
| Full Name | Dr Thomas Shaw |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 13260 N 94th Dr Ste 102, Peoria, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043643794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | S020052 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Shaw, PHARMD 1034 W Spur Dr, Phoenix, AZ 85085-6369 Ph: (602) 509-2863 | Dr Thomas Shaw, PHARMD 13260 N 94th Dr Ste 102, Peoria, AZ 85381-4242 Ph: (623) 583-2045 |
News Archive
A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer (TNBC), which has generally been unresponsive to hormone receptor-targeted treatments, can indeed be treated using vitamin D and androgen receptor-targeted therapy.
Inhibitex, Inc., announced today that it has recently commenced dosing in a 90-patient randomized, placebo controlled, treatment guided, Phase 2 clinical trial to evaluate the safety, tolerability and antiviral activity of INX-189 in combination with pegylated interferon and ribavirin in chronic HCV-infected genotype 2 and 3 treatment naïve patients.
Physicians at Indiana University School of Medicine and the Northwest Radiology Network (Indianapolis, Indiana) report the case of a 17-year-old high school football player with second impact syndrome (SIS). A rare and devastating traumatic brain injury, SIS occurs when a person, most often a teenager, sustains a second head injury before recovery from an earlier head injury is complete.
Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products to treat life-threatening infectious diseases, today announced that it amended an existing agreement with the National Institutes of Health (NIH) to significantly broaden the licensed therapeutic indications, or "field of use," for Sequella's lead drug candidate, SQ109.
› Verified 1 days ago
Margaret Ann Johnson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7448 W Thunderbird Rd, Peoria, AZ 85381 Phone: 923-979-0558 | |
Ashorena Mezdo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7522 W Cinnabar Ave, Peoria, AZ 85345 Phone: 602-561-0926 | |
Gretchen A Magsam, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10641 W Olive Ave, 1662, Peoria, AZ 85345 Phone: 623-583-6688 | |
Dr. Adrijana Kekic, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10374 W Cashman Dr, Peoria, AZ 85383 Phone: 623-261-6594 Fax: 602-863-0015 | |
Mr. Edward M Shimon, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13640 N Plaza Del Rio Blvd # 110, Peoria, AZ 85381 Phone: 623-974-0436 Fax: 623-974-3161 | |
Erica Sykes, PHARMACIST INTERN Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8375 W Deer Valley Rd, Peoria, AZ 85382 Phone: 623-561-5196 | |
Janae Anne Lonski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9069 W Lake Pleasant Pkwy, Peoria, AZ 85382 Phone: 623-376-0549 Fax: 623-362-3431 |